Medicine and Dentistry
Nodular Melanoma
100%
Mitogen-Activated Protein Kinase
80%
Combination Therapy
60%
Neoplasm
40%
Immunity
40%
Tumor Cell
40%
Transcriptomics
40%
Evolution
40%
Immunotherapy
20%
Disease Exacerbation
20%
Progressive Disease
20%
Serositis
20%
Antigen Presentation
20%
Methylation
20%
Exhaustion
20%
Lymphoid Enhancer Factor 1
20%
Cross Resistance
20%
Programmed Death-Ligand 1
20%
Analysis
20%
Patient
20%
T Cell
20%
Cytotoxic T-Cell
20%
Cell Compartment
20%
INIS
melanomas
100%
therapy
60%
tumors
40%
tumor cells
40%
diseases
40%
dynamics
40%
immunity
40%
patients
20%
compartments
20%
enrichment
20%
losses
20%
mutations
20%
inflammation
20%
immunotherapy
20%
antigens
20%
methylation
20%
Biochemistry, Genetics and Molecular Biology
Mitogen-Activated Protein Kinase
80%
Immunity
40%
Evolution
40%
Transcriptomics
40%
Dynamics
40%
Mutation
20%
T Cell
20%
Methylation
20%
Antigen Presentation
20%
CD8
20%
CpG Site
20%
Cross Resistance
20%
Contrast
20%
Lymphoid Enhancer-Binding Factor 1
20%
PD-L1
20%
YAP1
20%
T Cell Deficiency
20%